Even if the capacity of blood GFAP and NfL levels to differentiate AD from FTD has already been investigated, with variable findings, to date, p-Tau181 is more suitable in the differential diagnosis of these disorders, showing its high diagnostic value [39,40,42,55,56,59,60,61]. This evidence concerns the gene GFAP and frontotemporal dementia.